Literature DB >> 9645346

Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung.

R T Pirinen1, R H Tammi, M I Tammi, P K Pääkkö, J J Parkkinen, U M Agren, R T Johansson, M M Viren, U Törmänen, Y M Soini, V M Kosma.   

Abstract

A series of 85 lung/bronchial tissue samples from 76 patients consisting of normal, metaplastic and dysplastic epithelium and different types of lung carcinomas were analyzed for the distribution of hyaluronan (HA), using a biotinylated hyaluronan binding complex as an HA-specific probe. The normal pseudo-stratified columnar bronchial epithelium was either negative for HA or displayed a weak staining around the basal cells. The epithelia of serous and mucous bronchial glands were HA negative whereas the submucosal connective tissue was strongly positive. In metaplastic, dysplastic and carcinoma in situ lesions the whole epithelium from basal to uppermost cells expressed HA on plasma membranes. Epithelial HA was also found in squamous cell carcinomas, but not in adenocarcinomas, carcinoid tumors or small cell carcinomas of the lung. Whereas epithelial HA was present in all lesions of the squamous cell type, the staining intensity displayed great local variability in 50% of the cases with severe dysplasia, carcinoma in situ and squamous cell carcinomas. In squamous cell carcinomas, such an irregular staining pattern was significantly associated with poor differentiation. Our results indicate that the expression of HA in different bronchial lesions and lung tumors is restricted to those showing squamous cell differentiation, being absent from other types of lung carcinomas. The increase of HA depleted areas in poorly differentiated squamous cell carcinomas emphasizes the important role of HA in tumor differentiation. HA on carcinoma cell surface may influence tumor growth and metastatic behavior.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645346     DOI: 10.1002/(sici)1097-0215(19980619)79:3<251::aid-ijc7>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.

Authors:  Hanna Siiskonen; Kari Törrönen; Timo Kumlin; Kirsi Rilla; Markku I Tammi; Raija H Tammi
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

2.  Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress.

Authors:  Mark E Lauer; Serpil C Erzurum; Durba Mukhopadhyay; Amit Vasanji; Judith Drazba; Aimin Wang; Csaba Fulop; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

3.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.

Authors:  Aditya G Kohli; Saul Kivimäe; Matthew R Tiffany; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

4.  Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.

Authors:  Yoshihiro Nishida; Warren Knudson; Cheryl B Knudson; Naoki Ishiguro
Journal:  Exp Cell Res       Date:  2005-04-21       Impact factor: 3.905

5.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.

Authors:  J M Karjalainen; R H Tammi; M I Tammi; M J Eskelinen; U M Agren; J J Parkkinen; E M Alhava; V M Kosma
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.

Authors:  Naohisa Futamura; Hiroshi Urakawa; Eisuke Arai; Eiji Kozawa; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2013-01-04       Impact factor: 5.150

7.  Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.

Authors:  Kozo Hosono; Yoshihiro Nishida; Warren Knudson; Cheryl B Knudson; Takahiro Naruse; Yoshitaka Suzuki; Naoki Ishiguro
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.

Authors:  E Arai; Y Nishida; J Wasa; H Urakawa; L Zhuo; K Kimata; E Kozawa; N Futamura; N Ishiguro
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

9.  Expression of hyaluronan in human tumor progression.

Authors:  Rajeev K Boregowda; Hitesh N Appaiah; Manjunath Siddaiah; Sunil B Kumarswamy; Sunila Sunila; K N Thimmaiah; KarunaKumar Mortha; Bryan Toole; Shib d Banerjee
Journal:  J Carcinog       Date:  2006-01-10

10.  Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy.

Authors:  M P Rangel; V K de Sá; V Martins; J R M Martins; E R Parra; A Mendes; P C Andrade; R M Reis; A Longatto-Filho; C Z Oliveira; T Takagaki; D M Carraro; H B Nader; V L Capelozzi
Journal:  Braz J Med Biol Res       Date:  2015-05-08       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.